“The fuel that powers tomorrow’s reactors — and that only one country currently makes at commercial scale.” A uranium product enriched beyond conventional reactor fuel but below weapons grade, essential for the advanced nuclear fleet now under construction.
Executive Summary
High-Assay Low-Enriched Uranium is uranium enriched to between 5% and 20% U-235 — above the 3–5% enrichment of conventional light-water reactor fuel, but below the 90%+ level constituting weapons-grade highly enriched uranium (HEU). HALEU is required as fuel for most advanced reactor designs currently under development and deployment: microreactors, small modular reactors (SMRs), and Gen IV designs including TerraPower’s Natrium (sodium-cooled fast reactor), X-energy’s Xe-100 (pebble-bed high-temperature gas reactor), and Kairos Power’s fluoride salt designs. The critical vulnerability: as of 2024–2025, Russia’s TENEX (subsidiary of Rosatom) was the only commercial-scale HALEU producer globally. Western advanced reactor programs face the paradox of deploying next-generation nuclear technology to reduce energy dependence — while depending on Russia for the fuel to run it.
The Strategic Mechanism
HALEU’s supply chain bottleneck has structural causes:
Why HALEU supply is concentrated:
- Conventional enrichment capacity globally is calibrated to 3–5% LEU for light-water reactors — the dominant reactor type for 60 years
- Producing HALEU requires either extending enrichment processes to higher assay levels or operating dedicated enrichment capacity
- Only TENEX has invested in commercial-scale HALEU production aligned with advanced reactor specifications
- U.S. domestic enrichment capacity (Urenco USA, the only U.S. enrichment plant) is not currently configured for HALEU at commercial volumes
Nonproliferation complexity:
- HALEU enriched to 19.75% (just below 20% threshold) sits uncomfortably close to the proliferation-sensitive range, requiring robust material controls
- Transportation, storage, and handling requirements for HALEU are more stringent than conventional LEU
- International Atomic Energy Agency safeguards apply, but the closer to 20% enrichment, the higher the proliferation concern
U.S. policy response:
- The 2024 ADVANCE Act and CHIPS-equivalent nuclear provisions included funding for domestic HALEU production
- The U.S. Prohibited Importation Act (2024) phased out Russian uranium imports, imposing hard deadlines on Rosatom fuel dependence
- DOE awarded HALEU production contracts to Centrus Energy (the only U.S. entity with licensed HALEU enrichment capability) and to X-energy for deconversion services
Market & Policy Impact
- Advanced reactor timeline risk: TerraPower’s Natrium demonstration project in Wyoming faced explicit HALEU supply-driven delays into 2025–2026, illustrating how fuel unavailability constrains the most advanced Western reactor projects
- Russian leverage: Prior to the 2024 import ban, ~12% of U.S. reactor fuel came from Rosatom-linked entities — HALEU dependence would have been structurally greater for advanced fleets
- EU vulnerability: European advanced reactor programs have no domestic HALEU source and face a longer lead time to qualified alternatives
- Centrus bottleneck: Centrus’s Piketon, Ohio facility is licensed for HALEU but at demonstration-scale volumes; scaling to commercial supply requires significant capital investment and regulatory approvals
- Canada and enrichment: Orano (French, Canadian operations) and Urenco are exploring HALEU enrichment expansions, but timelines lag advanced reactor deployment schedules
Modern Case Study: TerraPower Natrium Delay and HALEU Policy Response, 2023–2025
TerraPower — founded by Bill Gates — publicly disclosed in 2023 that its Natrium demonstration plant in Kemmerer, Wyoming faced a delay of at least two years, directly attributable to the absence of a domestic HALEU supply chain. The company had planned to source HALEU from Russia; sanctions and supply disruptions following the Ukraine invasion made that pathway untenable. TerraPower engaged DOE in an emergency supply arrangement and Centrus began limited HALEU production at Piketon in late 2023 — the first U.S. domestic HALEU production since the Cold War. Congress responded with the 2024 Prohibiting Russian Uranium Imports Act, which banned Rosatom-sourced uranium (with limited waivers through 2027) and appropriated $2.7 billion to develop domestic enrichment capacity. By 2025, the legislative architecture for a domestic HALEU supply chain was in place, but physical production capacity remained years behind demand projections for the advanced reactor fleet under construction — meaning the fuel gap will constrain advanced nuclear deployment through the late 2020s regardless of policy intent.